Human hepatocytes are the in vitro system of choice to study drug-induced 
m..... Urea synthesis serves as a parameter for the catabolic process maintained by the hepatocytes. The pathway involves a number of different enzymatic steps, is highly specific for hepatocytes and cannot be performed by any other cells within the liver. An additional advantage is that both products can easily be detected in the cell culture medium without interfering with cellular viability. Furthermore, the release of lactate dehydrogenase activity was assayed as a marker for cellular vitality, and the cell cultures underwent a visual microscopic control.
Introduction
The liver is the centralorgan of energy metabolism, biotransformation and synthesis of plasma proteins under physiological and pathophysiological conditions. Primary hepatocytes are an important model system to analyse and study liver specific processes and functions. So far, most of the studies with hepatocyte cultures have primarily been performed with rat hepatocytes. However, interspecies differences in all aspects of hepatocyte function exist and have been recognised and investigated for more than 30 years (for review see Runge et al., 2000a and references therein) . In addition, from data obtained in animal experiments one cannot always predict the effect any given drug might have in man. Therefore, primary human hepatocytes should be the system of choice for the evaluation of liver specific functions in humans, including (i) the biology of human viral liver pathogens or parasites and (ii) phase I and 11 drug metabolism (Moshage and Yap 1992, Li et al., 1997) .
Since human hepatocytes are available only in limited number, the development of culture systems that allow cultivation of differentiated and functional hepatocytes is of great importance. These human hepatocyte cultures should allow the establishment of screening systems for cytochrome P450 inducers and the investigation of drug-drug interactions. Given the fact that the read-out for these screening systems can be non-invasive assays, like for testosterone-6ß-hydroxylase (CYP3A4) or ethoxyresorufin-deethylase (CYPIA), it should be possible for such a culture system to allow repetitive treatment/wash-out cycles to screen for drug activity.
Here we present HEPAC 2 , a standardised and validated long-term serum-free 2 Characterisation, standardisation and validation of HEPAC 2 Selection of parameters. Which parameters should be used to evaluate the functionality of a given human hepatocyte culture system? Usually, maintenance of liver-specific functions is monitored by measuring the expression of serum proteins and/or drug metabolising enzymes by RT-PCR or Northern blot analysis for RNA detection and by Western blot analysis for pro tein detection. However, these methods are invasive and require the disruption of the cells. In addition, the quality of these markers as parameters for hepatocyte specific function is arguable for two reasons: First, the detection of a certain mRNA alone does not necessarily indicate the presence of the corresponding protein. Second, even if the protein is detectable by Western blot analysis, one cannot draw any conclusion on its functionality, because cofactors required for enzymatic activities might be missing (Runge et al., 2000b) .
Therefore, we decided to monitor hepatocellular function by tracking two products that are synthesised and secreted by hepatocytes. We chose (i) albumin synthesis as a marker for anabolic reactions performed by the hepatocytes, and (ii) the synthesis and excretion of urea.
Methods
Isolation and culture of human hepatocytes: Human hepatocytes were isolated from liver resections by three-step collagenase perfusion (Strom et al., 1982; Strom et al., 1987) . The viability of cells was determined by trypan blue exclusion test. Only hepatocyte preparations with more than 70% viability were used in the experiments described below. Cells were plated onto collagen-coated 6-well-plates at a density of 10 6 cells per well using MEM (Minimal Essential Medium containing 500 ng/rnl insulin and 500 ug/ml gentamycin). Unless otherwise stated, the medium was changed after 3 to 12 h to HHMM (Human Hepatocyte Maintenance Medium; Runge et al., 2000b) , containing 10 ng/ml HGF and 20 ng/ml EGF. Medium was changed daily. All studies were performed in accordance with an ethical survey of the ethics commission of the Ärztekammer Mecklenburg-Vorpommern. 
Human hepatocytes were incubated with AAP, 100-2815 mg/I, or DMSO for control purposes for 24 h. The first incubation cyele was started on day 4 of the culture. After 24 h, medium was replaced by AAP-free culture medium and the hepatoeytes we~e eultured for 72 h in the absence of AAP. This incubation cyele was repeated every 4 days resulting in 24 h incubation with AAP on days 8, 12, 16, and 20. The experimental design is outlined in Figure 1 .
Biochemical Assays: The eell eulture medium was eolleeted every 24 h for analysis of eatabolic (urea release) and anabolie processes (albumin seeretion) and for the determination of cellular viability (Lactate-dehydrogenase aetivity). LDH activity was detected using the Aeroset e8000 system from Abbott (LDH-deteetion kit, 7D69-20). Urea release was deteeted by a two step enzymatie eonversion (urease / glutamate-dehydrogenase) using the Aeroset c8000 system from Abbott (Urea deteetion kit, 7D75-20/-30). Albumin release into the eulture medium was determined using a sandwich ELISA with antibodies obtained from Bethyl, using goat anti-human albumin (Bethyl, A80-129A) as eoating antibody and goat anti-human albumin-HRP eonjugate (Bethyl, A80-129P) as detection antibody.
Results
Cellular morphology: Cell morphology was assayed by light and eleetron mieroseopy. It is evident that although hepatoeytes are by far the most prominent eell type, the eultures consist of a mixed population of eells. The eells showed a typical morphology of mature hepatoeytes for up to 24 days, mainly mono-and binuelear eells were present (Fig. 2) . Eleetron mieroseopy revealed round shaped nuelei; mitochondria and Golgi apparatus were well established and maintained from early days in the eulture until at least day 24. At all time points, bile eanalieuli were readily apparent. Glycogen and desmosomes also developed during the culture, indicating metabolie activity as well as elose cell-cell eontacts. m.....
-------------~-
Cellular vitality: Cellular integrity was determined by measuring the enzymatic activities of lactate dehydrogenase (LDH) in the culture medium. We monitored the release of LDH in hepatocyte cultures in the presence or absence of growth factors, Initially, within 24 h after plating, LDH activity reached levels of about 8 umol/s/l, With ongoing culture the daily release of LDH enzymatic activity declined to basal levels of approximately 0.5 umol/s/l. This basal activity was maintained from day 3 to day 15. The addition of growth factors did not alter the release of LDH into the culture medium (Fig. 3 ).
Hepatocellular functions: Previously, we showed that expression of phase I drug metabolising enzymes like cytochrome P4503A4, lA2, 2El and others as weil as corresponding testosterone-öß-hydroxylase activity (CYP3A4) were maintained and/or remained inducible for more than 4 weeks within these cultures (Runge et al., 2000b) . Expression of liver specific transcription factors CIEBPa, HNF-3 and HNF-4 was maintained for several weeks (Runge et al., 2000c) . These factors are held responsible for the maintenance of hepatocyte specific gene expression. Cytochrome P450 3A4 protein expression and corresponding testosterone-öß-hydroxylase activity was maintained and/or remained inducible for up to 30 days (Runge et al., 2000b) . Here, we determined the release of urea as an example for catabolic function of the hepatocytes. Initially, within 24 h after plating, urea release reached levels of about 3-4 mmol/1. Within the next 24 h after plating, urea release dropped to about 1.5 mmol/1. In the absence of HOF and EOF, urea release dropped further to about 1 mmol/I within the next 24 h, reaching a new steady state that was stable at least until day 15. In the presence of growth factors, urea release was maintained from day 2 on at approximately 1.5 mmol/l (Fig. 4) . The presence of HOF and EOF seemed to improve urea synthesis and release in human hepatocytes. Statistical analysis using Student's t-test (two sided distribution, two sampIe equal variance) revealed a significantly higher urea release (p < 0.05) in HOF and EOF treated hepatocytes on days 6, 11, and 13, compared to hepatocytes cultured in the absence of these growth factors. In addition, we monitored albumin release as a parameter for hepatocellular anabolic activity. As seen with urea, albumin release reached a steady state between day 3 and 7 during the culture. In the absence of growth factors, albumin release declined from day 7 on. Again, the presence of HOF and EOF seemed to improve hepatoceJlular functions, since albumin release did not decline but was maintained at the level reached at around day 3 (data not shown).
Implementation of HEPAC
2 as a recyclable human hepatocyte culture system After having validated the functional stability of our human hepatocyte culture system, we started to implement a protocol that would take advantage of the robustness of this model system: We culture human hepatocytes in the presence of HOF and EOF until day 4, a time point by which the cells have adopted a new steady state with regard to albumin and urea production. At day 4 the cells are incubated for 24 h with the substance of interest. Then at day 5 the active substance is omitted and the hepatocytes are cultured for 3 days under standard conditions (wash out cycle). At day 8, a second 24 h incubation cycle with the substance of interest is introduced. Again, the next day the foreign substance is omitted, and s ...... HGF and EGF treated hepatocytes on days 6, 11, and 13, compared to hepatocytes cultured in the absence of these growth factars.
r-r-----r-r-r-r-r-r---the cells are again cultured under control conditions to wash out any remaining substance or product, As these assays used to determine (i) metabolism of the active substance and (ii) its influence on hepatocellular metabolism, are non-invasive and, assuming that the active substance is nontoxic, this incubationlwash out cycle may be repeated further until the hepatocytes lose the ability to metabolise the active substance (Fig. 1). 4.2 Acetaminophen as a model substance AAP, also known as paracetamol, is the first substance we used to evaluate our culture system. In the liver, AAP is detoxified via glucuronidation or sulphation. AAP hepatotoxicity is caused by its biotransformation to the reactive metabolite N-acetyl-p-benzoquinoneimine (NAPQI) mediated by CYP2El and CYP1A2. Unless NAPQI is conjugated with glutathione and subsequently excreted, it may bind to proteins and 2,50 2,00 co ..... Figure 1 , AAP was applied for 24 h on culture days 4, 8, 12, 16, and 20 . At day 4 high doses of AAP (2815 mg/l) diminished urea production by approximately 20% and albumin secretion by 70-80%. These effects were reversible. After removal of AAP, secretion of urea returned to control levels within 24 hand albumin secretion returned to normal levels within 72 h (Figs. 5, 6 ). Three days after removal of AAP, the hepatocytes were again incubated with AAP for 24 h. Again, AAP at a concentration of 2815 mg/l led to a decrease in urea production by 15-30% and albumin secretion by 70-80%. These effects could be repeated several times, no matter whether AAP was added on day 4 or after 2-3 weeks of culture.
Summary and outlook
In this report we have presented HEPAC Human hepatocytes were cultured in HHMM with growth factors. Medium was changed every 24 h. Albumin was detected in cell culture medium (control, black line). On the days indicated, AAP was added for 24 h. Albumin release before, during and after incubation with AAP was determined in the culture medium (red bars). Data represent means ± SD from two determinations of one representative donor out of a total of four different donors.
Dose 28-day Oral Toxicity Study in Rodents) and 408 (Repeated Dose 90-day Oral Toxicity Study in Rodents). Up to 60 animals are required for each study. Often, the results obtained with these animal studies are not in line with data obtained from human studies. HEPAC 2 allows us to culture differentiated human hepatocytes for 28 days or longer. This should give us a tool to analyse acute or repeated dose effects that chemieals may exert on human hepatocytes. If other human cells can be maintained in a comparable fashion as weIl, it might be pos sible to reduce the number of animal studies for the evaluation of repeated dose effects of chemicals.
